Doberstein Stephen K 4
4 · Forte Biosciences, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4
Doberstein Stephen K
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-12+50,000→ 50,000 totalExercise: $1.18Exp: 2032-05-12→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the thirty six (36) months following the Date of Grant, such that the shares subject to the option shall be fully vested on the third (3rd) anniversary of the Date of Grant. "Date of Grant" shall mean May 12, 2022.